Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Effective perioperative analgesia is crucial for reducing hospital stay in pediatric surgical patients. Opioid-based analgesia, although effective, may lead to respiratory depression in the postoperative period. Therefore, alternative regional anesthesia techniques such as penile block and sacral ESPB are increasingly preferred.
Sacral ESPB provides both somatic and visceral analgesia by blocking the dorsal and ventral rami of the spinal nerves. It has the potential to block the pudendal nerve and achieve bilateral effect with a single midline injection. However, comparative data between sacral ESPB and penile block in circumcision surgeries is limited.
Effective perioperative analgesia is crucial for reducing hospital stay in pediatric surgical patients. Opioid-based analgesia, although effective, may lead to respiratory depression in the postoperative period. Therefore, alternative regional anesthesia techniques such as penile block and sacral ESPB are increasingly preferred.
Sacral ESPB provides both somatic and visceral analgesia by blocking the dorsal and ventral rami of the spinal nerves. It has the potential to block the pudendal nerve and achieve bilateral effect with a single midline injection. However, comparative data between sacral ESPB and penile block in circumcision surgeries is limited.
In this prospective, double-blind, randomized controlled trial, 62 children aged 2 to 7 years undergoing elective circumcision at the Department of Pediatric Surgery of Diyarbakır Gazi Yaşargil Training and Research Hospital will be randomly assigned to two groups:
Group I will receive sacral ESPB using 0.8 mL/kg of 0.25% bupivacaine
Group II will receive a penile block using the same dosage and concentration.
Primary outcomes include intraoperative opioid use and postoperative rescue analgesic consumption within 24 hours. Secondary outcome includes time to discharge. Hemodynamic parameters and FLACC scores will be monitored at defined intervals.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I - Sacral ESPB | Active Comparator | Type: Procedure Name: Sacral Erector Spinae Plane Block Description: Ultrasound-guided sacral ESPB using 0.8 mL/kg of 0.25% bupivacaine |
|
| Group II - Penile Block | Active Comparator | Type: Procedure Name: Penile Block penile block using 0.8 mL/kg of 0.25% bupivacaine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 0.8 mL/kg of 0.25% bupivacaine | Drug | 0.8 mL/kg of 0.25% bupivacaine |
|
| Measure | Description | Time Frame |
|---|---|---|
| FLACC Pain Score | Postoperative pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale at 0, 15, 30, 45, 60, 90 minutes, and 2, 4, 6, 8, 10, 12, 18, and 24 hours after surgery. A FLACC score ≥4 will be treated with rescue analgesia. | From arrival in the recovery room until 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Total Perioperative Opioid and Rescue Analgesic Consumption | Measured as total intraoperative fentanyl usage and postoperative administration of paracetamol and ibuprofen. | Up to 24 hours postoperatively |
Not provided
Inclusion Criteria:
ASA I pediatric patients aged 2-7 years
Scheduled for elective circumcision
Informed consent obtained from parents/legal guardians
Exclusion Criteria:
ASA score other than I
Age <2 or >7 years
Known allergy to local anesthetics
Refusal to participate
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| ali K oÄŸuz, specialist doctor in anestesio | Contact | +905324683045 | alikendal.oguz@sbu.edu.tr |
Not provided
Not provided
Data sharing is currently under consideration. A final decision will be made after study completion and ethical approval.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D000588 |
| Amines |